-
Mitomycin C as a DNA-Repair Stress Probe
2026-09-19
Mitomycin C is an antitumor antibiotic that can do more than suppress proliferation: it can expose how DNA damage tolerance and apoptosis differ across cancer models. This article connects its assay use with emerging SCUBE3 biology while defining what the evidence does—and does not—support.
-
AP1903 Workflows for FKBP-Controlled Cell Ablation
2026-09-19
AP1903 provides a fast, tunable trigger for FKBP fusion proteins, enabling controlled protein activation and conditional cell ablation without changing transgene abundance. Combined with expression-level engineering from Kozak libraries, it supports more informative experiments that separate protein quantity from pathway activation.
-
Machine Learning for Senolytic Discovery
2026-09-18
The reference study shows that machine-learning models trained only on published screening data can identify new senolytic candidates despite small and heterogeneous datasets. Computational prioritization followed by human-cell validation uncovered ginkgetin, periplocin, and oleandrin, illustrating a cost-conscious route for early-stage drug discovery.
-
RBMS1 Loss Enables PD-L1 Blockade in TNBC
2026-09-18
The reference study identifies RBMS1 as a post-transcriptional regulator of PD-L1 stability in immune-cold triple-negative breast cancer. Its mechanistic model links RBMS1 loss to B4GALT1 mRNA destabilization, reduced PD-L1 glycosylation, enhanced PD-L1 degradation, and stronger T-cell-mediated tumor control, providing a rationale for combination immunotherapy strategies.
-
3X (DYKDDDDK) Peptide: FLAG Workflow Guide
2026-09-17
The 3X (DYKDDDDK) Peptide combines a compact, hydrophilic epitope with competitive elution for sensitive FLAG fusion-protein workflows. This guide connects affinity purification, immunodetection, metal-aware assay design, and structural biology to mechanistic studies such as the Legionella VipF–eIF3 investigation.
-
RUBCN in Breast Cancer: Prognostic and Therapeutic Insights
2026-09-17
Yang et al. identify RUBCN as an autophagy-associated gene linked to breast cancer prognosis, immune infiltration, proliferation, invasion, and autophagic activity. The study combines multi-cohort bioinformatics with molecular and cellular validation, while also defining the experiments still needed before RUBCN can be considered a clinically actionable target.
-
Bradykinin Workflows for Vascular Signaling
2026-09-16
Build more informative vascular assays with Bradykinin, an endothelium-dependent vasodilator that connects endothelial relaxation, permeability, tissue contraction, pain, and inflammation readouts. This practical guide combines controlled peptide handling with the multi-readout logic of a recent mitochondrial disease study to improve assay interpretation and troubleshooting.
-
Safe DNA Gel Stain: Practical Gel Workflow
2026-09-15
Safe DNA Gel Stain is a DNA and RNA gel stain for visualizing nucleic acids in agarose or acrylamide gels while supporting blue-light imaging as an alternative to routine UV exposure and ethidium bromide workflows. It is suitable for research gel documentation but is less effective for 100–200 bp DNA and is not intended for diagnostic or medical use.
-
Doxycycline Hyclate for MMP-Driven BBB Research
2026-09-15
Use Doxycycline hyclate as a mechanistic matrix metalloproteinases inhibitor to connect MMP activity with blood-brain barrier failure, neuronal apoptosis, and behavioral phenotypes. This workflow also shows how to manage solubility, vehicle controls, and carefully bounded extensions into antiviral and antimalarial research.
-
TaqI Restriction Endonuclease Protocol Guide
2026-09-14
TaqI Restriction Endonuclease provides rapid, sequence-specific cleavage of plasmid DNA, PCR products, and genomic DNA when the T↓CGA recognition site is present. It is intended for research workflows such as cloning and fragment analysis, not for diagnostic or medical use.
-
Discovery of Senolytics Using Machine Learning
2026-09-14
Smer-Barreto and colleagues developed a cost-conscious machine-learning workflow trained entirely on published data to identify compounds that selectively eliminate senescent cells. Computational screening followed by validation in human cell models identified ginkgetin, periplocin, and oleandrin, demonstrating how heterogeneous literature data can support early senolytic discovery.
-
Gap26 Connexin 43 Mimetic Peptide Workflows
2026-09-13
Gap26 enables controlled dissection of connexin 43 hemichannel and gap-junction signaling in calcium, ATP, vascular, and astrocyte assays. This practical guide combines product-backed handling parameters with a recent breakthrough cancer pain model to improve experimental design, controls, and troubleshooting.
-
Risedronate Sodium Research Workflows
2026-09-12
Build reproducible bone-metabolism assays around Risedronate Sodium, from FPPS inhibition and osteoclast assays to lung-targeted delivery studies. Practical dosing, formulation, and troubleshooting guidance helps distinguish mechanism-specific effects from solubility or exposure artifacts.
-
SB-3CT Gelatinase Inhibitor: Practical Workflows
2026-09-12
SB-3CT is a concentration-aware probe for separating MMP-2 and MMP-9 activity in extracellular-matrix assays. This guide translates recent Adamtsl3–MMP9 findings into practical workflows for perineuronal-net studies, tumor metastasis research, and neuroprotection in cerebral ischemia models.
-
5-EdU: From DNA Synthesis to Translational Insight
2026-09-11
A mechanistic and strategic guide to using 5-Ethynyl-2'-deoxyuridine (5-EdU) for S phase DNA synthesis detection, developmental birthdating, cell proliferation assays, tumor growth research, and tissue regeneration studies.